241 filings
8-K
PRPH
ProPhase Labs Inc
18 Apr 24
Entry into a Material Definitive Agreement
8:00am
8-K
PRPH
ProPhase Labs Inc
15 Mar 24
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages
8:00am
8-K
PRPH
ProPhase Labs Inc
4 Jan 24
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
8:05am
8-K
PRPH
ProPhase Labs Inc
9 Nov 23
ProPhase Labs Announces Financial Results
8:00am
8-K
PRPH
ProPhase Labs Inc
10 Aug 23
ProPhase Labs Announces Financial Results
8:00am
8-K
17mbd1prcypckl
29 Jun 23
Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navidea
8:05am
8-K
1u8yybgvv4znf
22 Jun 23
Regulation FD Disclosure
8:35am
8-K
ibk5yhsyk91dbpg5m
20 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
em7je3qptnq8
20 Jun 23
Departure of Directors or Certain Officers
4:15pm
8-K
qhj0d1 2s
11 May 23
ProPhase Labs Announces Financial Results
8:10am
8-K
v8udg3ucmln wsfmj
25 Apr 23
Regulation FD Disclosure
8:20am
8-K
5kuu2hxg092iglkg
6 Apr 23
Departure of Directors or Certain Officers
4:15pm
8-K
igock2 x0o5o
28 Mar 23
ProPhase Labs Announces Record Financial Results
8:05am
8-K
jla 3bl8kpliylo7v
15 Mar 23
ProPhase Labs Announces New $6 Million Stock Repurchase Program
8:05am
8-K
ob5ko659wxm38cnus qx
1 Mar 23
Company in Early Stages of Exploring Development for Commercialization in Other Countries
8:05am
8-K
bxi p3mbw4lvmj8uc
22 Feb 23
Goal to launch commercially in Q4 2023
8:05am
8-K
ayyinpf 5c5qew
15 Feb 23
ProPhase Labs Announces Plans for Major Expansion of its Pharmaloz Manufacturing, Inc. Subsidiary to Meet Growing Demand
8:05am
8-K
wav81od
6 Feb 23
ProPhase Labs Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy
9:29am
8-K
gay1obt73ykh
30 Jan 23
Entry into a Material Definitive Agreement
4:30pm
8-K
hcih2k657o8y6l tb
5 Jan 23
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
8:10am